Chernyshov PV (2026). [PMID: 40690334](https://pubmed.ncbi.nlm.nih.gov/40690334/). *Int J Dermatol*. [Review / Meta-Analysis]
Lam PD (2026). [PMID: 41660300](https://pubmed.ncbi.nlm.nih.gov/41660300/). *Therapeutic advances in ophthalmology*. [Case Report / Case Series]
Ferrari G (2026). [PMID: 41827440](https://pubmed.ncbi.nlm.nih.gov/41827440/). *Journal of clinical medicine*. [Case Report / Case Series]
Dienes S (2026). [PMID: 41689384](https://pubmed.ncbi.nlm.nih.gov/41689384/). *International journal of dermatology*. [Basic Science / Preclinical]
Verma A (2026). [PMID: 41521800](https://pubmed.ncbi.nlm.nih.gov/41521800/). *Ocular immunology and inflammation*. [Basic Science / Preclinical]
Nanda A (2026). [PMID: 41678328](https://pubmed.ncbi.nlm.nih.gov/41678328/). *J Eur Acad Dermatol Venereol*. [Review / Meta-Analysis]
Luboń W (2026). [PMID: 41744821](https://pubmed.ncbi.nlm.nih.gov/41744821/). *Cells*. [Review / Meta-Analysis]
Shawver J (2025). [PMID: 39751769](https://pubmed.ncbi.nlm.nih.gov/39751769/). *Ophthalmology and therapy*. [Review / Meta-Analysis]
Truong-Balderas K (2025). [PMID: 40873394](https://pubmed.ncbi.nlm.nih.gov/40873394/). *Ocular immunology and inflammation*. [Case Report / Case Series]
Nguyen C (2025). [PMID: 40368030](https://pubmed.ncbi.nlm.nih.gov/40368030/). *The ocular surface*. [Case Report / Case Series]
